Novo Nordisk
NVO
#92
Rank
โ‚น19.874 T
Marketcap
โ‚น4,496
Share price
-0.17%
Change (1 day)
3.04%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.254 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.37 Billion. In 2025 the company made an earning of โ‚น1.997 Trillion, an increase over its 2024 earnings that were of โ‚น1.879 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.254 T12.89%
2025 โ‚น1.997 T6.28%
2024 โ‚น1.879 T28.01%
2023 โ‚น1.468 T57.81%
2022 โ‚น930.32 B5.24%
2021 โ‚น884.03 B12.38%
2020 โ‚น786.63 B13.11%
2019 โ‚น695.47 B-3.45%
2018 โ‚น720.31 B1.88%
2017 โ‚น707.00 B4.3%
2016 โ‚น677.83 B10.32%
2015 โ‚น614.41 B7.47%
2014 โ‚น571.72 B3.4%
2013 โ‚น552.91 B19.09%
2012 โ‚น464.29 B15.58%
2011 โ‚น401.72 B16.58%
2010 โ‚น344.59 B25.66%
2009 โ‚น274.23 B10.68%
2008 โ‚น247.78 B55.82%
2007 โ‚น159.02 B7.02%
2006 โ‚น148.58 B19.05%
2005 โ‚น124.80 B10.55%
2004 โ‚น112.89 B
2002 โ‚น76.06 B-14.39%
2001 โ‚น88.84 B-52.82%
2000 โ‚น188.28 B250%
1999 โ‚น53.79 B31.21%
1998 โ‚น40.99 B34.31%
1997 โ‚น30.52 B11.46%
1996 โ‚น27.38 B9.03%
1995 โ‚น25.11 B-3.15%
1994 โ‚น25.93 B-0.67%
1993 โ‚น26.10 B45.38%
1992 โ‚น17.95 B-13.81%
1991 โ‚น20.83 B37.12%
1990 โ‚น15.19 B-0.79%
1989 โ‚น15.31 B26.2%
1988 โ‚น12.13 B24.97%
1987 โ‚น9.71 B-0.9%
1986 โ‚น9.79 B-7.78%
1985 โ‚น10.62 B24.87%
1984 โ‚น8.51 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.009 T-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.965 T 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น729.77 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น914.49 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA